Talos Therapeutics

Jordi Serrats

17 Sept 2026reporter.nih.gov

National Institute on Aging

Optimization of brain-permeable CK2 inhibitors to inhibit neuroinflammation and metabolic dysfunction in Alzheimer's diseaseR43AG099398US$497.6k17 Sept 2026reporter.nih.gov